Effects of a nonpeptide bradykinin B2 receptor antagonist, FR167344, on different in vivo animal models of inflammation

British Journal of Pharmacology

Volumn 122, Issue 7, 1997, Pages 1436-1440

  Asano, Masayuki ^a   Hatori, Chie ^a   Inamura, Noriaki ^a   Sawai, Hiroe ^a   Hirosumi, Jiro ^a   Fujiwara, Tatsujiro ^a   Nakahara, Kunio ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Antagonist; B2 receptor; Bradykinin; FR167344; Nonpeptide; Oedema; Orally active; Pain; Pancreatitis

Indexed keywords

3 BROMO 8 [2,6 DICHLORO 3 [N [4 (N,N DIMETHYLCARBAMOYL)CINNAMIDOACETYL] N METHYLAMINO]BENZYLOXY] 2 METHYLIMIDAZO[1,2 A]PYRIDINE; AMYLASE; BRADYKININ B2 RECEPTOR ANTAGONIST; CARRAGEENAN; CERULETIDE; KAOLIN; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; INFLAMMATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PANCREAS DISEASE; PAW EDEMA; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; WRITHING TEST;

EID: 0030814857     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701534     Document Type: Article

References (39)

1. ARAMORI, I., ZENKOH, J., MORIKAWA, N., O'DONNELL, N., ASANO, M., NAKAMURA, K., IWAMI, M., KOJO, H. & NOTSU, Y. (1997). Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657. Mol. Pharmacol., 51, 171-176.
2. 2 receptor antagonist, FR173657. Br. J. Pharmacol., 120, 617-624.
3. BERTRAND, C., NADEL, J.A., YAMAWAKI, I. & GEPPETTI, P. (1993). Role of kinins in the vascular extravasation evoked by antigen and mediated by tachykinins in guinea pig trachea. J. Immunol., 151, 4902-4907.
4. BHOOLA, K.D., FIGUEROA, C.D. & WORTHY, K. (1992). Bioregulation of kinins: Kallikreins, kininogens, and kininases. Pharmacol. Rev., 44, 1-80.
5. BURCH, R.M., FARMER, S.G. & STERANKA, L.R. (1990). Bradykinin receptor antagonists. Med. Res. Rev., 10, 237-269.
6. CHERONIS, J.C., WHALLEY, E.T., NGUYEN, K.T., EUBANKS, S.R., ALLEN, L.G., DUGGAN, M.J., LOY, S.D., BONHAM, K.A. & BLODGETT, J.K. (1992). A new class of bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers. J. Med. Chem., 35, 1563-1572.
7. COSTELLO, A.H. & HARGREAVES, K.M. (1989). Suppression of carrageenin-induced hyperalgesia, hyperthermia and edema by a bradykinin antagonist. Eur. J. Pharmacol., 171, 259-263.
8. CRUWYS, S.C., GARRETT, N.E., PERKINS, M.N., BLAKE, D.R. & KIDD, B.L. (1994). The role of bradykinin B1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen-induced arthritis. Br. J. Pharmacol., 113, 940-944.
9. 9-bradykinin: possible role of interleukin-1. Br. J. Pharmacol., 103, 1057-1066.
10. DRAPEAU, G., CHOW, A & WARD, P.E. (1991). Metabolism of bradykinin analogs by angiotensin I converting enzyme and carboxypeptidase N. Peptides, 12, 631-638.
11. DUPUY, G., HILAIRE, G. & AUBRY, C. (1987). Rapid determination of α-amylase activity by use of a new chromogenic substrate. Clin. Chem., 33, 524-528.
12. 8]-bradykinin) in different in vivo animal models of inflammation. J. Pharmacol. Exp. Ther., 273, 1078-1084.
13. 2 receptor antagonist, in vitro and in vivo. J. Pharmacol. Exp. Ther., 273, 1071-1077.
14. FUJIYOSHI, T., DOZEN, M., IIDA, H., IKEDA, K., HAYASHI, I. & OHISHI, S. (1990). Demonstration of kinin-release in the peritoneal exudate of kaolin-induced writhing in mice. Jpn. J. Pharmacol., 53, 255-258.
15. FUJIYOSHI, T., HAYASHI, I. & OH-ISHI, S. (1989). Kaolin-induced writhing response in mice: Activation of the plasma kallikrein-kinin system by kaolin. J. Pharmacobio-Dyn., 12, 132-136.
16. GRIESBACHER, T. & LEMBECK, F. (1992). Effects of the bradykinin antagonist, HOE 140, in experimental acute pancreatitis. Br. J. Pharmacol., 107, 356-360.
17. GRIESBACHER, T., TIRAN, B. & LEMBECK, F. (1993). Pathological events in experimental acute pancreatitis prevented by the bradykinin antagonist, Hoe 140. Br. J. Pharmacol., 108, 405-411.
18. HALL, J.M. (1992). Bradykinin receptors: Pharmacological properties and biological roles. Pharmacol. Ther., 56, 131-190.
19. 2 receptor antagonist WIN 64338 in vivo and in vitro. Br. J. Pharmacol., 116, 3164-3168.
20. HEAPY, C.G., SHAW, J.S. &. FARMER, S.C. (1993). Differential sensitivity of antinociceptive assays to the bradykinin antagonist HOE 140. Br. J. Pharmacol., 108, 209-213.
21. HESS, J.F., BORKOWSKI, J.A., YOUNG, G.S. STRADER, C.D. & RANSOM, R.W. (1992). Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem. Biophy. Res. Commun., 184, 260-268.
22. HOCK, F.J., WIRTH, K., ALBUS, U., LINZ, W., GERHARDS, H.J., WIEMER, G., HENKE, S., BREIPOHL, G., KÖNIG, W., KNOLLE, J. & SCHÖLKENS, B.A. (1991). Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol., 102, 769-773.
23. 2 receptor antagonist, FR 167344. Eur. J. Pharmacol., 333, 79-86.
24. 1 bradykinin receptor. J. Biol. Chem., 269, 21583-21586.
25. MIZUMURA, K., MINAGAWA, M., TSUJII, T. & KUMAZAWA, T. (1990). The effects of bradykinin agonists and antagonists on visceral polymodal receptor activities. Pain, 40, 221-227.
26. 9]-BK and HOE 140, in two models of persistent hyperalgesia in the rat. Pain, 53, 191-197.
27. 1 receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat. Br. J. Pharmacol., 110, 1441-1444.
28. 1 receptor-dependent vasoconstriction following balloon catheter injury to the rabbit carotid artery. Br. J. Pharmacol., 111, 1029-1034.
29. REGOLI, D. & BARABÉ, J. (1980). Pharmacology of bradykinin and related peptides. Pharmacol. Rev., 32, 1-46.
30. 1 receptors for kinins in the rabbit by a bacterial lipopolysaccharide. Eur. J. Pharmacol., 71, 105-115.
31. 2 receptor antagonist. Proc. Natl. Acad. Sci. U.S.A., 91, 4693-4697.
32. SHIMIZU, I., WADA, S., OKAHISA, T., KAMAMURA, M., YANO, M., KODAIRA, T., NISHINO, T., SHIMA, K. & ITO, S (1993). Radioimmunoreactive plasma bradykinin levels and histological changes during the course of cerulein-induced pancreatitis in rats. Pancreas, 8, 220-225.
33. STEER, M.L. & MELDOLESI, J. (1987). The cell biology of experimental pancreatitis. N. Engl. J. Med., 316, 144-150.
34. STEWART, J.M. (1995). Bradykinin antagonists: development and applications. Biopolymers, 37, 143-155.
35. WHALLEY, E.T., CLEGG, S, STEWART, J.M. & VAVREK, R.J. (1987). The effect of kinin agonist and antagonists on the pain response of the human blister base. Naunyn-Schmiedeberg's Arch. Pharmacol., 336, 652-655.
36. WILLEMER, S., BIALEK, R., KOEHLER, H. & ADLER, G (1990). Caerulein-induced acute pancreatitis in rats: changes in glycoprotein-composition of subcellular membrane systems in acinar cells. Histochemistry, 95, 87-96.
37. WINTER, C.A., RISLEY, E.A. & NUSS, G.W. (1962). Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc. Soc. Exp. Biol., 111, 544-547.
38. 1 receptor antagonist. Eur. J. Pharmacol., 205, 217-218.
39. WIRTH, K., HOCK, F.J., ALBUS, U., LINZ, W., ALPERMANN, H.G., ANAGNOSTOPOULOS, H., HENK, S., BREIPHOL, G., KÖNIG, W., KNOLLE, J. & SCHÖLKENS, B.A. (1991b). Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br. J. Pharmacol., 102, 774-777.